Microfluidic systems in testicular in vitro culture: a powerful model tool for spermatogenesis and reprotoxicity studies.
- Author:
Botho Maximilian SCHNEIDER
1
;
Hande Irem HAMURCU
;
Andrea SALZBRUNN
;
Kathrein von KOPYLOW
Author Information
- Publication Type:Review
- Keywords: microfluidics; reprotoxicity; spermatogonial stem cells; testis; testis-on-chip
- MeSH: Humans; Male; Spermatogenesis/physiology*; Testis/cytology*; Cryopreservation; Cell Culture Techniques/methods*; Microfluidics/methods*; Animals
- From: Asian Journal of Andrology 2025;27(6):659-668
- CountryChina
- Language:English
- Abstract: As prepubertal boys do not yet produce spermatozoa, they cannot rely on sperm cryopreservation for fertility preservation before gonadotoxic therapy, such as high-dose alkylating agents or radiotherapy in the case of childhood cancers. According to the current guidelines, cryopreservation of testicular biopsies containing spermatogonial stem cells (SSCs) may be proposed to high-risk patients for potential later therapeutic use to fulfill the patients' wish for a biological child. One promising technique for human in vitro spermatogenesis and in vitro propagation of human SSCs is microfluidic (MF) culture, in which cells or tissues are subjected to a continuous flow of medium. This provides exact control over such parameters as nutrient content and gradients, as well as the removal of waste metabolites. While MF has been shown to maintain tissues and cell populations of organs for longer than conventional in vitro culture techniques, it has not been widely used for testicular in vitro culture. MF could advance human testicular in vitro culture and is also applicable to reprotoxicity studies. This review summarizes the findings and achievements of testis-on-chip (ToC) setups to date and discusses the benefits and limitations of these for spermatogenesis in vitro and toxicity assessment.
